ConductScience.org, home

Trial · NCT07885683

MagSense® Human Epidermal Growth Factor Receptor 2 (HER2) Imaging Agent (MSH2IA)

NCT07885683, Phase 1, Phase 2, Not yet recruiting, Imagion Biosystems, Inc.

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. MagSense® Human Epidermal Growth Factor Receptor 2 (HER2) Imaging Agent (MSH2IA). Trials, record NCT07885683. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07885683

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
MagSense® Human Epidermal Growth Factor Receptor 2 (HER2) Imaging Agent (MSH2IA)
NCT number
NCT07885683
Status
Not yet recruiting
Phases
Phase 1, Phase 2
Enrollment
70 participants, estimated
Lead sponsor
Imagion Biosystems, Inc.
Conditions
HER2-positive Breast Cancer
Interventions
The MagSense® HER2 Imaging Agent (MSH2IA)
First posted
2026-10-21
Last updated
2026-10-21

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPhase 1b: Level of Fe in blood24 hours post injectionPK MSH2IA Fe concentration \> LLOQ in human whole blood
PrimaryPhase 2 (Imaging Schedule): Dose and Imaging schedule for MSH2IA24 hours post injectionMSH2IA dose to image suspicious versus normal nodes and Post dose MRI imaging timing
PrimaryPhase 2 (Diagnostic Performance): Diagnostic performance comparison between MSH2IA and SOC24 hours post injectionPatient level concordance of MSH2IA imaging to clinical pathology and Patient level concordance of MSH2IA to AxUS as measured by PPV, NPV, and Overall Predictive Concordance (PPV+NPV).
SecondarySafety and Tolerability of MSH2IA Across All PhasesFrom baseline through 1 yearAll Phases: Assess safety and tolerability of MSH2IA Incidence and severity of AEs, serious adverse events and Injection site reactions (ISRs)

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers12

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
2470152BACKGROUNDPubMed
3798106BACKGROUNDPubMed
7677468BACKGROUNDPubMed
10963602BACKGROUNDPubMed
12904519BACKGROUNDPubMed
17330229BACKGROUNDPubMed
20194857BACKGROUNDPubMed
20498394BACKGROUNDPubMed
21278441BACKGROUNDPubMed
23000897BACKGROUNDPubMed

1 to 10 of 12

See all 12 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07885683

GET https://conductscience.org/api/trials/v1/NCT07885683/registered